Nov 24 (Reuters) - First Venture Sweden Private AB FIRSTb.ST:
SPRINT BIOSCIENCE SELLS CANCER PROGRAM TREX1 TO GILEAD SCIENCES
DEAL INCLUDES $14 MILLION UPFRONT AND UP TO $400 MILLION MILESTONES
Further company coverage: [FIRSTb.ST]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.